ES8800896A1 - Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina - Google Patents

Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina

Info

Publication number
ES8800896A1
ES8800896A1 ES557754A ES557754A ES8800896A1 ES 8800896 A1 ES8800896 A1 ES 8800896A1 ES 557754 A ES557754 A ES 557754A ES 557754 A ES557754 A ES 557754A ES 8800896 A1 ES8800896 A1 ES 8800896A1
Authority
ES
Spain
Prior art keywords
oxabicicloheptano
diamides
substituted
procedure
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557754A
Other languages
English (en)
Other versions
ES557754A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of ES8800896A1 publication Critical patent/ES8800896A1/es
Publication of ES557754A0 publication Critical patent/ES557754A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE DIAMIDAS SUSTITUIDAS CON 7-OXABICICLOHEPTANO Y SUS ANALOGOS DE PROSTAGLANDINA. CONSISTE EN HACER REACCIONAR A UN COMPUESTO DE FORMULA (I) (R-CO2H) CON UN COMPUESTO DE FORMULA (II), PARA OBTENER UN COMPUESTO DE FORMULA (I) (R CONR4-OR5). SIENDO: A, CHFCH O -CH2-CH2-; R1 Y R2, H O ALQUILO INFERIOR; R3, H, ALQUILO INFERIOR, ARILO Y OTROS; R4 Y R5, H, HIDROXI, ALCOXI INFERIOR Y OTROS; Q, -CH2-CHOH-CNFCH- Y OTROS; M, DE 0 A 4; N, DE 1 A 5; P, DE 1 A 4; Q, DE 1 A 12. SE UTILIZA PARA EL TRATAMIENTO DE LA TROMBOSIS CEREBRAL Y LA BRONCOCONSTRICCION.
ES557754A 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina Expired ES8800896A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75094885A 1985-07-01 1985-07-01
US06/853,788 US4663336A (en) 1985-07-01 1986-04-18 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease

Publications (2)

Publication Number Publication Date
ES8800896A1 true ES8800896A1 (es) 1987-12-01
ES557754A0 ES557754A0 (es) 1987-12-01

Family

ID=27115346

Family Applications (10)

Application Number Title Priority Date Filing Date
ES556530A Expired ES8801626A1 (es) 1985-07-01 1986-06-24 Procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina.
ES557753A Expired ES8802020A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557750A Expired ES8801899A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557748A Expired ES8801898A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557752A Expired ES8802019A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557754A Expired ES8800896A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557746A Expired ES8802016A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557749A Expired ES8900229A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557751A Expired ES8802018A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557747A Expired ES8802017A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina

Family Applications Before (5)

Application Number Title Priority Date Filing Date
ES556530A Expired ES8801626A1 (es) 1985-07-01 1986-06-24 Procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina.
ES557753A Expired ES8802020A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557750A Expired ES8801899A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557748A Expired ES8801898A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557752A Expired ES8802019A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES557746A Expired ES8802016A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557749A Expired ES8900229A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557751A Expired ES8802018A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557747A Expired ES8802017A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina

Country Status (20)

Country Link
US (1) US4663336A (es)
EP (1) EP0207684B1 (es)
JP (1) JPH07103125B2 (es)
KR (1) KR910004721B1 (es)
CN (1) CN1009645B (es)
AT (1) ATE114312T1 (es)
AU (1) AU603058B2 (es)
CA (1) CA1284643C (es)
DE (1) DE3650144T2 (es)
DK (1) DK162528C (es)
ES (10) ES8801626A1 (es)
FI (1) FI93218C (es)
GR (1) GR861711B (es)
HU (1) HU196779B (es)
IE (1) IE65827B1 (es)
IL (1) IL79210A (es)
NO (1) NO168038C (es)
NZ (1) NZ216544A (es)
PH (1) PH22413A (es)
PT (1) PT82875B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ218115A (en) * 1985-11-18 1990-02-26 Shionogi & Co Bicyclic sulphonamides and pharmaceutical compositions
US4958036A (en) * 1986-06-04 1990-09-18 E. R. Squibb & Sons, Inc. Enantiomerically selective synthesis of certain N-substituted-2-(carbamyl 7-oxabicyclo[2.2.1]heptane-3-carboxylic acids
US4743697A (en) * 1986-06-04 1988-05-10 E. R. Squibb & Sons, Inc. Process for preparing 7-oxabicycloheptane amino-alcohol intermediates useful in making thromboxane A2 receptor antagonists and novel intermediates procuced therein
US4749715A (en) * 1987-03-02 1988-06-07 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amino prostaglandin analogs
US4931460A (en) * 1987-09-17 1990-06-05 E. R. Squibb & Sons, Inc. Post-ischemic myocardial dysfunction using thromboxane A2 antagonists
US5066480A (en) * 1988-04-11 1991-11-19 E. R. Squibb & Sons, Inc. Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist
USH1139H (en) 1988-07-21 1993-02-02 E. R. Squibb & Sons, Inc. Combination of a calcium channel blocker and thromboxane A2 receptor antagonist or synthetase inhibitor and method for treating ischemia employing such combination
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US4839384A (en) * 1988-10-07 1989-06-13 E. R. Squibb & Sons, Inc. Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist
US4965279A (en) * 1988-11-18 1990-10-23 E. R. Squibb & Sons, Inc. Cyclopropyl aza prostaglandin analogs
US5100889A (en) * 1989-04-03 1992-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5153327A (en) * 1988-12-23 1992-10-06 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
CA2006086A1 (en) * 1989-01-17 1990-07-17 A. K. Gunnar Aberg Method of preventing or treating atherosclerosis using a thromboxane a receptor antagonist
CA2007896A1 (en) * 1989-02-06 1990-08-06 A.K. Gunnar Aberg Method of treating hypertension using a thromboxane a2 receptor antagonist and new combinations
CA2012852A1 (en) * 1989-05-01 1990-11-01 Miguel A. Ondetti Method of inhibiting vasospasm and platelet aggregation resulting from angioplasty using thromboxane a receptor antagonists
US4977174A (en) * 1989-06-12 1990-12-11 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US4975279A (en) * 1989-10-10 1990-12-04 E. R. Squibb & Sons, Inc. Method of improving post-ischemic myocardial function using a thromboxane A2 antagonist in combination with a thrombolytic agent and combination
US5141865A (en) * 1989-11-17 1992-08-25 E. R. Squibb & Sons, Inc. Monoclonal antibodies which bind thromboxane A2 receptor antagonists and diagnostic methods based thereon
US4978762A (en) * 1990-02-26 1990-12-18 E. R. Squibb & Sons, Inc. Process for preparing [1S-[1α,2α)Z),3α,4α]]-7-[3-[[[[[1-oxoheptyl]-amino]acetyl]amino]methyl]-7-oxabicyclo-[2,2,1]hept-2-yl]-5-heptenoic acid
US5081266A (en) * 1990-02-26 1992-01-14 E. R. Squibb & Sons, Inc. Process for preparing [1S-[1α,2α(Z),3α,4α]]-7-[3-[[[[(1-oxoheptyl)-amino]acetyl]amino]methyl]-7-oxabicyclo-[2.2.1]hept-2-yl]-5-heptenoic acid
JP2984077B2 (ja) * 1990-04-19 1999-11-29 塩野義製薬株式会社 スルホニルアミノ置換ビシクロ環系ヒドロキサム酸誘導体
DE69109953T2 (de) * 1990-07-27 1995-09-21 Zeneca Ltd Alfa-fluorocarbonsäurederivate als Zwischenprodukte zur Herstellung von Fungiziden.
US5290799A (en) * 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
CA2055572A1 (en) * 1990-12-18 1992-06-19 David Kronenthal Processes and intermediates for thromboxane receptor antagonists
US5266710A (en) * 1990-12-18 1993-11-30 Patel Ramesh N (Exo,exo)-7-oxabicyclo[2.2.1]heptane-2,3-dimethanol; monoacyl ester and diacyl ester
US5245055A (en) * 1990-12-18 1993-09-14 E. R. Squibb & Sons, Inc. Process for preparing a cis oxabicyclo olefinic acid and ester from an oxabicyclo pyranol
US5084387A (en) * 1990-12-18 1992-01-28 E. R. Squibb & Sons, Inc. Microbiological hydrolysis for the preparation of (exo,exo)-7-oxabicyclo(2.2.1) heptane-2,3, monoacyl ester dimethanol
US5084581A (en) * 1990-12-18 1992-01-28 E. R. Squibb & Sons, Inc. Process for preparing (3R-(3aα,4β,7ββ,7aα))-octahydro-4,7 epoxyisobenzofuranol from associated aldehydes
US5126370A (en) * 1990-12-24 1992-06-30 E. R. Squibb & Sons, Inc. Anti-thrombotic heterocyclic amido prostaglandin analogs
US5135939A (en) * 1991-01-28 1992-08-04 E. R. Squibb & Sons, Inc. Heterocyclic ketone prostaglandin analogs
US5158967A (en) * 1991-06-12 1992-10-27 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) * 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
WO2003099272A1 (en) * 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
WO2004046104A2 (en) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2015176060A1 (en) 2014-05-16 2015-11-19 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
US12161632B2 (en) 2014-05-16 2024-12-10 Cumberland Pharmaceuticals Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
CN114569608A (zh) 2015-06-30 2022-06-03 坎伯兰医药品股份有限公司 Aerd/哮喘中的血栓烷受体拮抗剂
US10064845B2 (en) 2016-05-11 2018-09-04 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4368332A (en) * 1979-01-05 1983-01-11 National Research Development Corporation Prostaglandins
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
GB2113678B (en) * 1981-12-23 1985-06-19 Nat Res Dev Prostaglandins
KR840003462A (ko) 1982-05-14 1984-09-08 데이빗 핸더슨 복합성분의 가소물질투여 및 혼합총
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease
US4456615A (en) 1982-10-25 1984-06-26 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction
US4456617A (en) * 1983-01-12 1984-06-26 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction
US4533673A (en) * 1984-01-26 1985-08-06 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted enaminone prostaglandin analogs and their use in treatment of thrombolytic disease
US4536514A (en) * 1984-04-06 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin analogs useful in the treatment of thrombolytic disease
US4654356A (en) * 1985-08-01 1987-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted diacid diamide prostaglandin analogs

Also Published As

Publication number Publication date
ES8801898A1 (es) 1988-03-01
ES8802017A1 (es) 1988-03-16
DK162528B (da) 1991-11-11
ES8802016A1 (es) 1988-03-16
ES557750A0 (es) 1988-03-01
IL79210A0 (en) 1986-09-30
CN1009645B (zh) 1990-09-19
ES557749A0 (es) 1989-04-01
ES8802020A1 (es) 1988-03-16
DK162528C (da) 1992-03-30
ATE114312T1 (de) 1994-12-15
IE861749L (en) 1987-01-01
US4663336A (en) 1987-05-05
FI93218C (fi) 1995-03-10
IE65827B1 (en) 1995-11-15
HUT45041A (en) 1988-05-30
AU5871586A (en) 1987-01-08
DK310686A (da) 1987-01-02
ES557747A0 (es) 1988-03-16
DK310686D0 (da) 1986-06-30
NO862635L (no) 1987-01-02
PT82875A (en) 1986-07-01
AU603058B2 (en) 1990-11-08
EP0207684A3 (en) 1987-04-29
ES557754A0 (es) 1987-12-01
FI862797A7 (fi) 1987-01-02
FI862797A0 (fi) 1986-07-01
NO168038B (no) 1991-09-30
KR910004721B1 (ko) 1991-07-10
HU196779B (en) 1989-01-30
ES556530A0 (es) 1988-02-16
KR870001229A (ko) 1987-03-12
PT82875B (pt) 1988-04-21
ES8802019A1 (es) 1988-03-16
DE3650144T2 (de) 1995-04-06
NZ216544A (en) 1990-02-26
JPH07103125B2 (ja) 1995-11-08
ES8900229A1 (es) 1989-04-01
DE3650144D1 (de) 1995-01-05
ES557748A0 (es) 1988-03-01
ES8802018A1 (es) 1988-03-16
ES8801626A1 (es) 1988-02-16
FI93218B (fi) 1994-11-30
EP0207684A2 (en) 1987-01-07
PH22413A (en) 1988-08-26
GR861711B (en) 1986-11-03
NO168038C (no) 1992-01-08
IL79210A (en) 1991-03-10
EP0207684B1 (en) 1994-11-23
JPS6263589A (ja) 1987-03-20
ES557752A0 (es) 1988-03-16
CN86105664A (zh) 1987-02-18
ES557746A0 (es) 1988-03-16
NO862635D0 (no) 1986-06-30
ES557751A0 (es) 1988-03-16
ES8801899A1 (es) 1988-03-01
ES557753A0 (es) 1988-03-16
CA1284643C (en) 1991-06-04

Similar Documents

Publication Publication Date Title
ES8800896A1 (es) Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
DE69001187D1 (de) 6-epifumagillole, ihre herstellung und ihre verwendung.
FI852974A0 (fi) Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner.
AR240830A2 (es) Procedimiento para preparar derivados de acidos naftiridin quinolin-y benzoxazincarboxilicos.
ES542940A0 (es) Procedimiento para preparar un compuesto seleccionado del grupo constituido de la 7-halo-7-desoxilincomicina y analo- gos de la misma
AR241474A1 (es) Preparacion de derivados de acido 3-aciltriciclo ¡5.2.1.0(2.6)¿-3-azadecan-4-carboxilico utiles como inhibidores de la enzima convertidora en angiotensina.
HUT45984A (en) Process for production of quinoline-derivatives and of their medically acceptable acid-additioned salts
HUT45053A (en) Process for producing 7-(/meta-substituted/-phenyl-glycin-amido)-1-carba-1-detia-cefems
FR2368488A1 (fr) Procede pour la preparation de methoxypsoralene
FR2446838A1 (fr) Derives peptidiques d'acides phosphoniques
ES8708136A1 (es) Procedimiento para la obtencion de derivados de acido barbiturico
FR2359832A1 (fr) 1,3,5-tris-(2-chloroformyl-oxyethyl)-isocyanurate
ES8800220A1 (es) Procedimiento para la produccion de 8-alfa-acilamino-ergolinas.
DK382288D0 (da) Thiophenderivat og fremgangsmaade til fremstilling deraf
DE3677465D1 (de) N-glykolylneuraminsaeurederivat.
ES8306997A1 (es) Procedimiento para preparar un derivado de prostaglandina.
FR2380271A1 (fr) Acides halogene-benzofuranone-carboxyliques utiles comme intermediaires de synthese
ES8200092A1 (es) Procedimiento para la sintesis de esteres de la n-(4'hidro- xifenil) acetamida con acidos 5-benzoil-1-metilpirrol-2-ace-tico
GB2002350A (en) Preparation of tetramisole intermediate
FR2355813A1 (fr) Procede de preparation de n-(2-cyanophenyl)-formiamidines
ES8705363A1 (es) Un procedimiento para preparar derivados de tetrahidronaftaleno
FR2453160A1 (fr) Procede de preparation de quinazolinones
ES8505654A1 (es) Procedimiento para preparar derivados de piridilaminoeteno
FR2379524A1 (fr) Procede pour la preparation de benzylpyrimidines
SE8400451L (sv) Bronkutvidgande azapinol(1-2-a)pyrimidinderivat och syraadditionssalter derav samt farmaceutiska kompositioner innehallande desamma

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000601